In focus · trending topic

molecular disease screening

9 stories · following the connections

Quotient Limited Announces CFO Transition

By Nasdaq OMXNov 2, 2016, 8:15 PM UTC

Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ™ and Second Quarter Fiscal 2017 Financial Results

By Nasdaq OMXOct 31, 2016, 8:14 PM UTC

Quotient Limited Announces Booth Tour at the 2016 AABB Annual Meeting and Provides Update of Expected Timing of Internal Evaluation Study Results

By Nasdaq OMXOct 21, 2016, 12:31 PM UTC

Quotient Limited to Report Second Quarter Fiscal 2017 Financial Results and Host Conference Call

By Nasdaq OMXOct 17, 2016, 12:30 PM UTC

Quotient Limited Announces $120 Million Secured Debt Financing

By Nasdaq OMXOct 14, 2016, 8:01 PM UTC

Quotient Limited Announces Successful Validation of the Initial Manufacturing System for MosaiQ™ Microarrays

By Nasdaq OMXSep 8, 2016, 8:05 PM UTC

Quotient Limited Announces Positive MosaiQ™ Serological Disease Screening Results

By Nasdaq OMXApr 13, 2016, 8:06 PM UTC

Quotient Limited Announces Positive Serological Disease Screening Results and Provides MosaiQ™ Development Program Update

By Nasdaq OMXJan 11, 2016, 12:01 PM UTC